We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cesarean Birth Increases Mother's Mortality Risk

By HospiMedica staff writers
Posted on 18 Sep 2006
Women who opt for an elective cesarean have a threefold higher risk of mortality than those who choose vaginal delivery, according to a new study.

Researchers from Hopital Tenon (Paris, France) and the Universite Pierre et Marie Curie (Paris, France) examined postpartum maternal mortality using a national surveillance program in France that included 269 deaths during the five-year study period from 1996 to 2000. More...
The researchers narrowed their analysis to 65 maternal deaths that did not occur before delivery or after hospitalization, ensue from chronic illness during pregnancy, or result in multiple births. A control group consisted of 13,478 live term births in France recorded in the 1998 French National Perinatal Study.

Women who died during or within 42 days of giving birth were significantly more likely to have had a cesarean than women who survived childbirth (41.5% versus 14.9%). Both cesarean deliveries initiated before onset of labor and those initiated during labor significantly increased risk of maternal death. Cesareans were associated with a significantly increased risk of postpartum maternal death compared with vaginal delivery even after adjusting for age, nationality, parity, and premature birth with an odds ratio of 3.64. The odds decreased only slightly to 3.3 after excluding preterm births. The study was published in the September 2006 issue of Obstetrics & Gynecology.

The increased maternal mortality was caused primarily by venous thrombosis (25.9%), infection (14.8%), and anesthesia complications (14.8%). Postpartum hemorrhage was no higher for cesarean deliveries. None of these complications were among the most frequent causes of death after vaginal births. Postpartum hemorrhage was actually a less common cause of death following cesarean delivery than after vaginal birth (22.2% versus 50.0%).

"Although cesarean delivery is increasingly perceived as a low-risk procedure, it is still associated with an increased risk of postpartum maternal death compared with vaginal delivery, even when performed before labor,” said lead author Catherine Deneux-Tharaux, M.D., M.P.H, and colleagues.



Related Links:
Universite Pierre et Marie Curie

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.